EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[ColonTODAY 095 - Solitary rectal ulcer syndrome]

Previous | Next


1. Introduction to solitary rectal ulcer syndrome (SRUS)

Solitary rectal ulcer syndrome(SRUS)Àº ÀÌ»óÇÑ º´ÀÔ´Ï´Ù. À̸§°ú ´Þ¸® solitary ÇÏÁö ¾ÊÀº °æ¿ìµµ ¸¹°í ulcer°¡ ¾Æ´Ñ °æ¿ìµµ ÀÖ½À´Ï´Ù. ¿øÀÎÀº ºÒ¸íÈ®Çѵ¥ straining µîÀÌ Áß¿äÇÏ°í, ³»½Ã°æ ¼Ò°ßÀº ´Ù¾çÇÕ´Ï´Ù. Á¶Á÷°Ë»ç¿¡¼­ ºñ±³Àû Ư¡ÀûÀÎ ¼Ò°ßÀÌ º¸ÀÔ´Ï´Ù.

Solitary¶ó´Â À̸§°ú ´Þ¸® multipleÇÑ °æ¿ì°¡ 25%, ulcer syndromeÀ̶ó´Â À̸§°ú ´Þ¸® ulcer°¡ ¾Æ´Ï¶ó protruded lesionÀÎ °æ¿ì°¡ 25%ÀÔ´Ï´Ù.


2. Cases of SRUS

2³â ÀüºÎÅÍ straining ÇÏ´Â ½À°üÀÌ ÀÖ´ø ºÐ

¼ú ¸¹ÀÌ µå½Ã´Â ´ç´¢È¯ÀÚÀÇ Ç÷º¯

Ulcer syndromeÀ̶ó´Â À̸§°ú ´Þ¸® À¶±âºÎ¿Í ÇÔ¸ôºÎ°¡ È¥ÀçµÇ¾ú´ø SRUS Áõ·Ê

¾Æ·¡´Â ´ëÇ׺´¿øÀÇ Ãֿ뼺 ¼±»ý´Ô²²¼­ ¾Öµ¶ÀÚ Áõ·Ê ÆíÁö 19·Î º¸³»Á̴ּø Áõ·ÊÀÔ´Ï´Ù.

30´ë ¿©¼º. ¹èº¯ ½Ã ÃâÇ÷À» ÁÖ¼Ò·Î ³»¿ø. Æò¼Ò º¯ºñ°¡ ½ÉÇÏ°í ÇÏ·ç 30ºÐ Á¤µµ È­Àå½Ç¿¡ ¾É¾Æ ÀÖÀ½. Ä¡ÇÙ ¹× Ä¡¿­·Î ¼ö¼úÇÑ º´·Â (+). º¯Àº ¸¶·Á¿îµ¥ ¾È ³ª¿À°í °¡½º°¡ ¸¹ÀÌ Âü.

³»½Ã°æ Á¶Á÷°Ë»ç: ulcerative granulation tissue with inflammatory exudate


3. Gut and Liver 2018¿¡ ½Ç¸° ¸ÚÁø ¸®ºä(Update on the Pathophysiology and Management of Anorectal Disorders)ÀÇ SRUS ÇØ´ç ºÎºÐ

Solitary rectal ulcer syndrome (SRUS) is characterized by either erythema or ulceration in the rectum. It is not necessarily solitary or ulcerated as multiple ulcers can be found in 30% of patients. It occurs commonly in the third or fourth decade with a slightly higher prevalence in females. The most accepted pathophysiology of SRUS is either direct trauma or local ischemia to the rectal mucosa. Ulceration is thought to occur during repeated forceful straining against an immobile pelvic floor leading to mucosal prolapse and/or direct trauma from digital manipulations. This may lead to venous congestion, poor blood flow, and edema in the rectal mucosa and ischemic changes with resulting in ulceration. Patients usually present with rectal bleeding, tenesmus, mucus discharge, straining, and a feeling of incomplete evacuation. Majority use digital maneuvers but rarely admit. About 20% to 40% have diarrhea, and 25% are misdiagnosed or treated as inflammatory bowel disease. In some patients, an underlying psychologic disorder, such as obsessive compulsive disorder may be present. Anorectal manometry studies demonstrated dyssynergic defecation together with delayed balloon expulsion time in 25% to 82% of patients with SRUS. Also, SRUS patients exhibited rectal hypersensitivity, high anal pressure and paradoxical puborectalis contraction during straining.

1) Diagnosis

The appearances of SRUS on endoscopy may vary from hyperemic changes to established ulcers on the anterior or anterolateral wall of the rectum at about 5 to 10 cm from anal verge. Lesions are usually shallow, 1 to 1.5 cm in size, and covered by a white, grey or yellowish slough. The adjacent mucosa may appear nodular, lumpy or granular. The lesions can be multiple (30%), ulcerated (57%), polypoid (25%) or with patches of hyperemic mucosa (18%). Biopsy confirmation is important and key histological features include fibromuscular proliferation of the lamina propria, hypertrophied muscularis mucosa with extension of muscle fibers upwards between the crypts, and glandular crypt abnormalities. Presence of diffuse collagen deposition in the lamina propria is a sensitive marker for differentiating SRUS from inflammatory bowel disease. Defecography may show other abnormalities such as rectal mucosal intussusception in 45% to 80% of subjects. Endoanal ultrasonography may show marked thickening of the IAS which is highly suggestive of coexisting high grade rectal intussusception.

2) Management

Although randomized controlled trials are scarce, behavioral therapy that includes refraining from using digital maneuvers together with biofeedback therapy remain the mainstay of treatment. This treatment combination improved symptoms including straining, and bleeding in 56% to 67% of patients with significant sigmoidoscopic improvement in 30% to 55%. An increase in rectal blood flow also demonstrated after biofeedback therapy.

Topical treatments, including sucralfate, salicylate, corticosteroids, sulfasalazine, mesalazine and topical fibrin sealant, have been reported to be effective in uncontrolled studies. A recent randomized controlled study suggests that argon plasma coagulation may be useful in controlling bleeding and improving healing of ulcers better than a standard of care.

Rectopexy with or without anterior resection should be performed in highly selected cases with an advanced grade of rectal intussusception and rectal prolapse. A study of 48 patients who underwent laparoscopic ventral mesh rectopexy after biofeedback therapy reported sustained improvement in quality of life and bowel symptoms score at 2 years in the 52% who were followed up for 3 to 15 years.

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.